Resilience-Building Intervention for Advance Care Planning
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment Culturally tailored resilience-building intervention for Advance Care Planning?
Research shows that culturally adapting advance care planning (ACP) interventions can improve communication and engagement in diverse communities, such as American Indian, Alaska Native, Latino, and African-American populations. These studies highlight the importance of incorporating cultural values and addressing barriers to enhance the effectiveness of ACP interventions.12345
Is the Resilience-Building Intervention for Advance Care Planning safe for humans?
The available research does not provide specific safety data for the Resilience-Building Intervention for Advance Care Planning, but similar culturally adapted psychosocial interventions have been reported as highly accepted by participants, suggesting they are generally well-received and likely safe.678910
How is the Culturally Tailored Resilience-Building Intervention for Advance Care Planning different from other treatments?
This treatment is unique because it is specifically designed to incorporate cultural values and priorities into advance care planning, making it more relevant and effective for American Indian and Alaska Native communities, who traditionally use advance care planning less than the general population.1231112
What is the purpose of this trial?
Less than 15% of Chinese Americans complete advance directives. That is less than half of the 37% completion rate in the US general population. This disparity in the use of advance care planning between White Americans and Chinese Americans may extend to disparities in end-of-life care. To address such disparities in end-of-life care, we will develop and assess the acceptability of a culturally tailored resilience-building intervention to help Chinese Americans with cancer or heart disease and their family caregivers engage in advance care planning discussions.
Eligibility Criteria
This trial is for Chinese Americans over 18 with cancer or heart failure who have a family caregiver willing to join the study. Participants must be able to respond in English or Mandarin and have their diagnosis recorded in medical records.Inclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Intervention Development
Development of a culturally tailored resilience-building intervention for Chinese Americans with cancer or heart disease
Usability Testing
Usability test of the resilience-building intervention prototype with 18 pairs of Chinese Americans and their family caregivers
Follow-up
Participants are monitored for acceptability of the intervention immediately after usability testing
Treatment Details
Interventions
- Culturally tailored resilience-building intervention
Culturally tailored resilience-building intervention is already approved in United States for the following indications:
- Advance Care Planning Discussions for Chinese Americans with Cancer or Heart Disease
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Illinois at Chicago
Lead Sponsor
University of Chicago
Collaborator
Rush University Medical Center
Collaborator
National Institute on Minority Health and Health Disparities (NIMHD)
Collaborator